Synopsys-Ansys Merger Augurs FTC's Return To Remedies
On May 28, the Federal Trade Commission signaled a shift in policy from the Biden administration and a return to accepting remedies to resolve competitive concerns when it approved the $35 billion merger...To view the full article, register now.
Already a subscriber? Click here to view full article